Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label, Multicenter Study With Follow-Up Evaluating the Safety and Efficacy of Varenicline Tartrate in Comparison to Transdermal Nicotine Patch for Smoking Cessation

NCT00143325 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00143325
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00143325 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label, Multicenter Study With Follow-Up Evaluating the Safety and Efficacy of Varenicline Tartrate in Comparison to Transdermal Nicotine Patch for Smoking Cessation
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2005
Completion date
June 30, 2006
Enrollment
730
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

smoking cessation